Abstract: A method and an apparatus for granting network permission to a terminal include receiving, by an authentication device, a network permission request packet sent by a terminal, granting, by the authentication device, first network permission to the terminal receiving, by the authentication device, a first authentication failure message sent by a server after granting the first network permission to the terminal, and withdrawing, by the authentication device, the first network permission of the terminal based on the first authentication failure message. Therefore, the authentication device can grant the network permission to the terminal before receiving an authentication result sent by the server, and withdraw the network permission in time when receiving the first authentication failure message sent by the server.

Abstract: A resistance structure, a resistance structure unit, an information identification device and a biosensor. The resistance structure comprises: a first electrode (1); a second electrode (2); a plurality of first resistance elements (3), wherein one end of each of the first resistance elements (3) is connected to the first electrode (1), and the other end thereof is connected to the second electrode (2); a first fracture (11), the first fracture (11) dividing the first electrode (1) into a first part (111) and a second part (112), the first fracture (11) being located between two adjacent first resistance elements (3) or disconnecting at least one first resistance element (3) from the first electrode (1); and a third electrode (4), wherein the third electrode (4) is connected to the first part (111) of the first electrode (1).

Abstract: An ECG system measures and annotates the P-point of an ECG waveform from harmonic waveforms. Electrical impulses are received from a beating heart. The electrical impulses are converted to an ECG waveform. The ECG waveform is converted to a frequency domain waveform, which, in turn, is separated into two or more different frequency domain waveforms, which, in turn, are converted into a plurality of time domain cardiac electrophysiological subwaveforms and discontinuity points between these subwaveforms. The plurality of subwaveforms and discontinuity points are compared to a database of subwaveforms and discontinuity points for normal and abnormal patients. A discontinuity point is identified as the P-point of the ECG waveform from the comparison. Similar measurements are made for the P?-point, I-point, J-point, and T?-point. Distances from these points to the equipotential line are calculated and used to detect blockages leading to myocardial infarction.

Abstract: A NAT entry management method and a NAT device are disclosed. The method includes: receiving and storing, by a NAT device, a connection parameter, where the connection parameter includes an address of a controller; receiving a packet sent by a network device, where a source address of the packet is a private address of the network device and a destination address of the packet is the address of the controller; performing NAT on the packet, where an after-NAT source address of the packet is a public address; and when a static entry condition is met, generating a target static NAT entry, where the static entry condition includes that the destination address of the packet is the address of the controller. This can prevent aging of the NAT entry from affecting communication between the network device and the controller.

Abstract: The present invention provides compositions and methods for delivery of therapeutic agents across an barrier. The compositions include a therapeutic agent (e.g., antimicrobial agent, antibiotic, or anesthetic agent), a permeation enhancer which increases the flux of the therapeutic agent across the barrier, and a matrix forming agent. The matrix forming agent forms a gel at a suitable gelation temperature and has rheological properties for use in drug delivery, and in some cases, the gelation temperature and rheological properties are not significantly changed from those of the composition without the permeation enhancer. The invention also provides a matrix forming agent and compositions thereof. Such compositions are particularly useful in the treatment of infectious disease (e.g., otitis media). Methods of treatment, methods of delivery, and kits for the compositions described herein are also provided.

Abstract: An ECG system measures and annotates a subdivision of the P wave of the ECG waveform from harmonic waveforms. Electrical impulses are received from a beating heart. The electrical impulses are converted to an ECG waveform. The ECG waveform is converted to a frequency domain waveform, which, in turn, is separated into two or more different frequency domain waveforms, which, in turn, are converted into a plurality of time domain cardiac electrophysiological subwaveforms and discontinuity points between these subwaveforms. The plurality of subwaveforms and discontinuity points are compared to a database of subwaveforms and discontinuity points for normal and abnormal patients. Starting and ending discontinuity points are identified for a subdivision of the P wave of the ECG waveform and an APD is calculated for the subdivision. The ECG waveform is displayed along with a location of the P wave subdivision on the ECG waveform and the calculated APD.

Abstract: A composition for use in the treatment of rosacea includes a multi-kinase inhibitor that inhibits both a Vascular Endothelial Growth Factor Receptor and a Fibroblast Growth Factor Receptor. A method for treating rosacea for a patient includes inhibiting a Vascular Endothelial Growth Factor Receptor of the patient; and inhibiting a Fibroblast Growth Factor Receptor of the patient.

Abstract: A power-outputting management method includes following steps. When a plurality of power-supplying apparatuses are in a working interval, if an output power ratio of the power-supplying apparatus in a working status is less than an output power ratio standard, at least one of the power-supplying apparatuses in the working status is turned off, so that the output power ratio of the power-supplying apparatus in the working status increases and meets the output power ratio standard. When the power-supplying apparatuses are in the working interval, if the output power ratio of the power-supplying apparatus in the working status meets the output power ratio standard, a power capping of the power-supplying apparatuses is set based on an actual power consumption of an electronic apparatus.

Abstract: A resistance structure, a resistance structure unit, an information identification device and a biosensor. The resistance structure comprises: a first electrode (1); a second electrode (2); a plurality of first resistance elements (3), wherein one end of each of the first resistance elements (3) is connected to the first electrode (1), and the other end thereof is connected to the second electrode (2); a first fracture (11), the first fracture (11) dividing the first electrode (1) into a first part (111) and a second part (112), the first fracture (11) being located between two adjacent first resistance elements (3) or disconnecting at least one first resistance element (3) from the first electrode (1); and a third electrode (4), wherein the third electrode (4) is connected to the first part (111) of the first electrode (1).

Abstract: Disclosed are methods of preparing antifouling and chlorine-resistant coatings on reverse osmosis membranes with initiated chemical vapor deposition. The coatings enhance the stability and lifetime of membranes without sacrificing performance characteristics, such as permeability or salt retention.

Abstract: A resistance structure, a resistance structure unit, an information identification device and a biosensor. The resistance structure comprises: a first electrode (1); a second electrode (2); a plurality of first resistance elements (3), wherein one end of each of the first resistance elements (3) is connected to the first electrode (1), and the other end thereof is connected to the second electrode (2); a first fracture (11), the first fracture (11) dividing the first electrode (1) into a first part (111) and a second part (112), the first fracture (11) being located between two adjacent first resistance elements (3) or disconnecting at least one first resistance element (3) from the first electrode (1); and a third electrode (4), wherein the third electrode (4) is connected to the first part (111) of the first electrode (1).

Abstract: Compositions and methods of using nintedanib for improving the success rate of glaucoma filtration surgery are disclosed herein. Nintedanib can be used alone or in combination with an anti-metabolite drug in a topical or implant eye formulation.

Abstract: A mount for a gas turbine engine unit. The mount comprises a unit interface for securing a unit to the mount. The unit interface comprises an internal cavity in communication with a cooling aperture to be overlaid by unit secured to the unit interface. The mount further comprises a structural framework for securing the mount to a gas turbine engine. The structural framework comprises an internal cooling conduit for delivering cooling airflow from an air source to the internal cavity of the unit interface.

Abstract: A power-outputting management method includes following steps. When a plurality of power-supplying apparatuses are in a working interval, if an output power ratio of the power-supplying apparatus in a working status is less than an output power ratio standard, at least one of the power-supplying apparatuses in the working status is turned off, so that the output power ratio of the power-supplying apparatus in the working status increases and meets the output power ratio standard. When the power-supplying apparatuses are in the working interval, if the output power ratio of the power-supplying apparatus in the working status meets the output power ratio standard, a power capping of the power-supplying apparatuses is set based on an actual power consumption of an electronic apparatus.

Abstract: Compositions and methods of using nintedanib for improving the success rate of glaucoma filtration surgery are disclosed herein. Nintedanib can be used alone or in combination with an anti-metabolite drug in a topical or implant eye formulation.

Abstract: The present invention provides topical dermal compositions including microsphere encapsulated isotretinoin. Pharmaceutically acceptable salts, esters, or amides of isotretinoin are also contemplated for use in the practice of the invention. The compositions of the invention are useful for treating a variety of conditions associated with excess sebum production, such as, for example, acne.

Abstract: The present invention provides a cup sleeve formed with a reverse damping structure having one or more rings inwardly bent and annularly arranged on one or both of the edge and the inner periphery of the cup sleeve, so when the mentioned cup sleeve is sleeved with a cup-shaped or bottle-shaped or can-shaped container, the anti-slip damping for enhancing the anti-loose function is provided by the reverse damping structure, thus the cup sleeve is less likely to be released from the cup-shaped or bottle-shaped or can-shaped container, and with the reverse damping structure, the interval formed between the cup sleeve and the cup-shaped or bottle-shaped or can-shaped container is enlarged thereby increasing the thermal insulation effect.

Abstract: There is provided a method of manufacturing a semiconductor device by processing a substrate, which includes: embedding a polymer having a urea bond in a recess formed in the substrate by supplying a material for polymerization from above a sacrificial film to the substrate and forming a polymer film made of the polymer having the urea bond, wherein a surface of the substrate is covered with the sacrificial film, the recess including an opening of the sacrificial film that is formed by a patterning; removing the polymer film formed on the sacrificial film while leaving the polymer embedded in the recess; removing the sacrificial film in a state in which the polymer is embedded in the recess; and subsequently, removing the polymer embedded in the recess.

Abstract: A pressure relief arrangement for a gas turbine engine comprises a hinged door and a mount. A plastically deformable member is provided between and coupled to the hinged door and the mount. The deformable member is configured to deform between a non-deformed state when the door is in a closed position and an elongated deformed state when the door is in an open position.

Abstract: A NAT entry management method and a NAT device are disclosed. The method includes: receiving and storing, by a NAT device, a connection parameter, where the connection parameter includes an address of a controller; receiving a packet sent by a network device, where a source address of the packet is a private address of the network device and a destination address of the packet is the address of the controller; performing NAT on the packet, where an after-NAT source address of the packet is a public address; and when a static entry condition is met, generating a target static NAT entry, where the static entry condition includes that the destination address of the packet is the address of the controller. This can prevent aging of the NAT entry from affecting communication between the network device and the controller.